Massive 100,000-Patient review aims to predict breast Cancer's return
NCT ID NCT07309887
Summary
This study looks back at the medical records of 100,000 Korean patients with a common type of early-stage breast cancer. The goal is to understand how often the cancer comes back after initial treatment and which factors influence that risk. Researchers will analyze data from patients treated between 2010 and 2023 to learn which treatments work best for long-term control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Samsung Medical Center
Seoul, 06351, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.